3,5-Dimethyl-H-furo[3,2-g]chromen-7-one as a potential anticancer drug by inducing p53-dependent apoptosis in human hepatoma HepG2 cells.

MLA

Sun, Jian-guo, et al. “3,5-Dimethyl-H-Furo[3,2-g]Chromen-7-One as a Potential Anticancer Drug by Inducing P53-Dependent Apoptosis in Human Hepatoma HepG2 Cells.” Chemotherapy, vol. 57, no. 2, 2011, pp. 162–72. EBSCOhost, https://doi.org/10.1159/000326915.

APA

Sun, J., Chen, C., Luo, K., Yeung, C. A., Tsang, T., Huang, Z., Wu, P., Fung, K., Kwok, T., & Liu, F. (2011). 3,5-Dimethyl-H-furo[3,2-g]chromen-7-one as a potential anticancer drug by inducing p53-dependent apoptosis in human hepatoma HepG2 cells. Chemotherapy, 57(2), 162–172. https://doi.org/10.1159/000326915

Chicago

Sun, Jian-guo, Chao-yue Chen, Ke-wang Luo, Chi-lam Au Yeung, Tsun-yee Tsang, Zhi-zhen Huang, Ping Wu, Kwok-pui Fung, Tim-tak Kwok, and Fei-yan Liu. 2011. “3,5-Dimethyl-H-Furo[3,2-g]Chromen-7-One as a Potential Anticancer Drug by Inducing P53-Dependent Apoptosis in Human Hepatoma HepG2 Cells.” Chemotherapy 57 (2): 162–72. doi:10.1159/000326915.